HeCaToS Newsletter November 2017

HeCaToS project has just completed its forth year and is now entering at
the final year. HeCaToS aims to establish in silico prediction models for
human heart and liver toxicity, and after four consecutive years of fruitful
collaboration between fourteen partners across Europe, interesting
results have been obtained and published in high impact journals. During
these four past years, we designed assays using 3D human cardiac and
hepatic cell models to mimic drug exposure to cardiac and liver toxicants
based on in vivo PK profiles.

Download the Newsletter 2017 issue 3 here